1 Market Overview of Glucocorticoid for Systemic Lupus Erythematosus 1.1 Glucocorticoid for Systemic Lupus Erythematosus Market Overview 1.1.1 Glucocorticoid for Systemic Lupus Erythematosus Product Scope 1.1.2 Glucocorticoid for Systemic Lupus Erythematosus Market Status and Outlook 1.2 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Region (2016-2027) 1.4 Global Glucocorticoid for Systemic Lupus Erythematosus Historic Market Size by Region (2016-2021) 1.5 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) 1.6.1 North America Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) 1.6.2 Europe Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) 1.6.3 Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) 1.6.4 Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) 1.6.5 Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) 2 Glucocorticoid for Systemic Lupus Erythematosus Market Overview by Type 2.1 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Glucocorticoid for Systemic Lupus Erythematosus Historic Market Size by Type (2016-2021) 2.3 Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size by Type (2022-2027) 2.4 Hydrocortisone 2.5 Prednison 2.6 Prednisolone 2.7 Triamcinolone Acetonide 2.8 Dexamethasone 2.9 Betamethasone 2.10 Other 3 Glucocorticoid for Systemic Lupus Erythematosus Market Overview by Application 3.1 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Glucocorticoid for Systemic Lupus Erythematosus Historic Market Size by Application (2016-2021) 3.3 Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Clinic 3.6 Pharmacy 3.7 Other 4 Glucocorticoid for Systemic Lupus Erythematosus Competition Analysis by Players 4.1 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucocorticoid for Systemic Lupus Erythematosus as of 2020) 4.3 Date of Key Players Enter into Glucocorticoid for Systemic Lupus Erythematosus Market 4.4 Global Top Players Glucocorticoid for Systemic Lupus Erythematosus Headquarters and Area Served 4.5 Key Players Glucocorticoid for Systemic Lupus Erythematosus Product Solution and Service 4.6 Competitive Status 4.6.1 Glucocorticoid for Systemic Lupus Erythematosus Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Pfizer 5.1.1 Pfizer Profile 5.1.2 Pfizer Main Business 5.1.3 Pfizer Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.1.4 Pfizer Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.1.5 Pfizer Recent Developments 5.2 Sanofi 5.2.1 Sanofi Profile 5.2.2 Sanofi Main Business 5.2.3 Sanofi Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.2.4 Sanofi Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.2.5 Sanofi Recent Developments 5.3 Teva 5.5.1 Teva Profile 5.3.2 Teva Main Business 5.3.3 Teva Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.3.4 Teva Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.3.5 Akorn Recent Developments 5.4 Akorn 5.4.1 Akorn Profile 5.4.2 Akorn Main Business 5.4.3 Akorn Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.4.4 Akorn Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.4.5 Akorn Recent Developments 5.5 GSK 5.5.1 GSK Profile 5.5.2 GSK Main Business 5.5.3 GSK Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.5.4 GSK Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.5.5 GSK Recent Developments 5.6 Bausch and Lomb 5.6.1 Bausch and Lomb Profile 5.6.2 Bausch and Lomb Main Business 5.6.3 Bausch and Lomb Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.6.4 Bausch and Lomb Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.6.5 Bausch and Lomb Recent Developments 5.7 Bayer Pharmas 5.7.1 Bayer Pharmas Profile 5.7.2 Bayer Pharmas Main Business 5.7.3 Bayer Pharmas Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.7.4 Bayer Pharmas Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.7.5 Bayer Pharmas Recent Developments 5.8 Fougera Pharms 5.8.1 Fougera Pharms Profile 5.8.2 Fougera Pharms Main Business 5.8.3 Fougera Pharms Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.8.4 Fougera Pharms Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.8.5 Fougera Pharms Recent Developments 5.9 Hikma Intl Pharms 5.9.1 Hikma Intl Pharms Profile 5.9.2 Hikma Intl Pharms Main Business 5.9.3 Hikma Intl Pharms Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.9.4 Hikma Intl Pharms Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.9.5 Hikma Intl Pharms Recent Developments 5.10 Impax Labs 5.10.1 Impax Labs Profile 5.10.2 Impax Labs Main Business 5.10.3 Impax Labs Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.10.4 Impax Labs Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.10.5 Impax Labs Recent Developments 5.11 Lannett 5.11.1 Lannett Profile 5.11.2 Lannett Main Business 5.11.3 Lannett Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.11.4 Lannett Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.11.5 Lannett Recent Developments 5.12 Merck 5.12.1 Merck Profile 5.12.2 Merck Main Business 5.12.3 Merck Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.12.4 Merck Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.12.5 Merck Recent Developments 5.13 Novartis 5.13.1 Novartis Profile 5.13.2 Novartis Main Business 5.13.3 Novartis Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.13.4 Novartis Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.13.5 Novartis Recent Developments 5.14 Sandoz 5.14.1 Sandoz Profile 5.14.2 Sandoz Main Business 5.14.3 Sandoz Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.14.4 Sandoz Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.14.5 Sandoz Recent Developments 5.15 TARO 5.15.1 TARO Profile 5.15.2 TARO Main Business 5.15.3 TARO Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.15.4 TARO Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.15.5 TARO Recent Developments 5.16 Valeant 5.16.1 Valeant Profile 5.16.2 Valeant Main Business 5.16.3 Valeant Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.16.4 Valeant Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.16.5 Valeant Recent Developments 5.17 Wockhardt 5.17.1 Wockhardt Profile 5.17.2 Wockhardt Main Business 5.17.3 Wockhardt Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.17.4 Wockhardt Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.17.5 Wockhardt Recent Developments 5.18 Solvay Pharma 5.18.1 Solvay Pharma Profile 5.18.2 Solvay Pharma Main Business 5.18.3 Solvay Pharma Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.18.4 Solvay Pharma Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.18.5 Solvay Pharma Recent Developments 5.19 Alcon 5.19.1 Alcon Profile 5.19.2 Alcon Main Business 5.19.3 Alcon Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.19.4 Alcon Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.19.5 Alcon Recent Developments 5.20 Paladin Labs 5.20.1 Paladin Labs Profile 5.20.2 Paladin Labs Main Business 5.20.3 Paladin Labs Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.20.4 Paladin Labs Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.20.5 Paladin Labs Recent Developments 5.21 Adcock Ingram 5.21.1 Adcock Ingram Profile 5.21.2 Adcock Ingram Main Business 5.21.3 Adcock Ingram Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.21.4 Adcock Ingram Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.21.5 Adcock Ingram Recent Developments 5.22 ADARE Pharmaceuticals 5.22.1 ADARE Pharmaceuticals Profile 5.22.2 ADARE Pharmaceuticals Main Business 5.22.3 ADARE Pharmaceuticals Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.22.4 ADARE Pharmaceuticals Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.22.5 ADARE Pharmaceuticals Recent Developments 5.23 Aspen Holdings 5.23.1 Aspen Holdings Profile 5.23.2 Aspen Holdings Main Business 5.23.3 Aspen Holdings Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.23.4 Aspen Holdings Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.23.5 Aspen Holdings Recent Developments 5.24 Astellas Pharma 5.24.1 Astellas Pharma Profile 5.24.2 Astellas Pharma Main Business 5.24.3 Astellas Pharma Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.24.4 Astellas Pharma Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.24.5 Astellas Pharma Recent Developments 5.25 Endo International 5.25.1 Endo International Profile 5.25.2 Endo International Main Business 5.25.3 Endo International Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.25.4 Endo International Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.25.5 Endo International Recent Developments 5.26 Sun Pharmaceutical 5.26.1 Sun Pharmaceutical Profile 5.26.2 Sun Pharmaceutical Main Business 5.26.3 Sun Pharmaceutical Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.26.4 Sun Pharmaceutical Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.26.5 Sun Pharmaceutical Recent Developments 5.27 Perrigo 5.27.1 Perrigo Profile 5.27.2 Perrigo Main Business 5.27.3 Perrigo Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.27.4 Perrigo Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.27.5 Perrigo Recent Developments 5.28 Aerosol 5.28.1 Aerosol Profile 5.28.2 Aerosol Main Business 5.28.3 Aerosol Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions 5.28.4 Aerosol Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) & (2016-2021) 5.28.5 Aerosol Recent Developments 6 North America 6.1 North America Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Glucocorticoid for Systemic Lupus Erythematosus Market Dynamics 11.1 Glucocorticoid for Systemic Lupus Erythematosus Industry Trends 11.2 Glucocorticoid for Systemic Lupus Erythematosus Market Drivers 11.3 Glucocorticoid for Systemic Lupus Erythematosus Market Challenges 11.4 Glucocorticoid for Systemic Lupus Erythematosus Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Share by Region (2016-2021) Table 4. Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size Share by Region (2022-2027) Table 6. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Type (2016-2021) Table 9. Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Type (2022-2027) Table 11. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Application (2016-2021) Table 14. Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Application (2022-2027) Table 16. Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (US$ Million) by Players (2016-2021) Table 17. Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucocorticoid for Systemic Lupus Erythematosus as of 2020) Table 19. Date of Key Manufacturers Enter into Glucocorticoid for Systemic Lupus Erythematosus Market Table 20. Global Glucocorticoid for Systemic Lupus Erythematosus Top Players Headquarters and Area Served Table 21. Glucocorticoid for Systemic Lupus Erythematosus Product Solution and Service Table 22. Global Glucocorticoid for Systemic Lupus Erythematosus Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Pfizer Basic Information List Table 25. Pfizer Description and Business Overview Table 26. Pfizer Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 27. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Pfizer (2016-2021) Table 28. Pfizer Recent Developments Table 29. Sanofi Basic Information List Table 30. Sanofi Description and Business Overview Table 31. Sanofi Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 32. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Sanofi (2016-2021) Table 33. Sanofi Recent Developments Table 34. Teva Basic Information List Table 35. Teva Description and Business Overview Table 36. Teva Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 37. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Teva (2016-2021) Table 38. Teva Recent Developments Table 39. Akorn Basic Information List Table 40. Akorn Description and Business Overview Table 41. Akorn Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 42. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Akorn (2016-2021) Table 43. Akorn Recent Developments Table 44. GSK Basic Information List Table 45. GSK Description and Business Overview Table 46. GSK Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 47. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of GSK (2016-2021) Table 48. GSK Recent Developments Table 49. Bausch and Lomb Basic Information List Table 50. Bausch and Lomb Description and Business Overview Table 51. Bausch and Lomb Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 52. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Bausch and Lomb (2016-2021) Table 53. Bausch and Lomb Recent Developments Table 54. Bayer Pharmas Basic Information List Table 55. Bayer Pharmas Description and Business Overview Table 56. Bayer Pharmas Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 57. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Bayer Pharmas (2016-2021) Table 58. Bayer Pharmas Recent Developments Table 59. Fougera Pharms Basic Information List Table 60. Fougera Pharms Description and Business Overview Table 61. Fougera Pharms Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 62. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Fougera Pharms (2016-2021) Table 63. Fougera Pharms Recent Developments Table 64. Hikma Intl Pharms Basic Information List Table 65. Hikma Intl Pharms Description and Business Overview Table 66. Hikma Intl Pharms Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 67. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Hikma Intl Pharms (2016-2021) Table 68. Hikma Intl Pharms Recent Developments Table 69. Impax Labs Basic Information List Table 70. Impax Labs Description and Business Overview Table 71. Impax Labs Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 72. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Impax Labs (2016-2021) Table 73. Impax Labs Recent Developments Table 74. Lannett Basic Information List Table 75. Lannett Description and Business Overview Table 76. Lannett Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 77. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Lannett (2016-2021) Table 78. Lannett Recent Developments Table 79. Merck Basic Information List Table 80. Merck Description and Business Overview Table 81. Merck Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 82. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Merck (2016-2021) Table 83. Merck Recent Developments Table 84. Novartis Basic Information List Table 85. Novartis Description and Business Overview Table 86. Novartis Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 87. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Novartis (2016-2021) Table 88. Novartis Recent Developments Table 89. Sandoz Basic Information List Table 90. Sandoz Description and Business Overview Table 91. Sandoz Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 92. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Sandoz (2016-2021) Table 93. Sandoz Recent Developments Table 94. TARO Basic Information List Table 95. TARO Description and Business Overview Table 96. TARO Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 97. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of TARO (2016-2021) Table 98. TARO Recent Developments Table 99. Valeant Basic Information List Table 100. Valeant Description and Business Overview Table 101. Valeant Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 102. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Valeant (2016-2021) Table 103. Valeant Recent Developments Table 104. Wockhardt Basic Information List Table 105. Wockhardt Description and Business Overview Table 106. Wockhardt Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 107. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Wockhardt (2016-2021) Table 108. Wockhardt Recent Developments Table 109. Solvay Pharma Basic Information List Table 110. Solvay Pharma Description and Business Overview Table 111. Solvay Pharma Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 112. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Solvay Pharma (2016-2021) Table 113. Solvay Pharma Recent Developments Table 114. Alcon Basic Information List Table 115. Alcon Description and Business Overview Table 116. Alcon Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 117. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Alcon (2016-2021) Table 118. Alcon Recent Developments Table 119. Paladin Labs Basic Information List Table 120. Paladin Labs Description and Business Overview Table 121. Paladin Labs Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 122. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Paladin Labs (2016-2021) Table 123. Paladin Labs Recent Developments Table 124. Adcock Ingram Basic Information List Table 125. Adcock Ingram Description and Business Overview Table 126. Adcock Ingram Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 127. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Adcock Ingram (2016-2021) Table 128. Adcock Ingram Recent Developments Table 129. ADARE Pharmaceuticals Basic Information List Table 130. ADARE Pharmaceuticals Description and Business Overview Table 131. ADARE Pharmaceuticals Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 132. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of ADARE Pharmaceuticals (2016-2021) Table 133. ADARE Pharmaceuticals Recent Developments Table 134. Aspen Holdings Basic Information List Table 135. Aspen Holdings Description and Business Overview Table 136. Aspen Holdings Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 137. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Aspen Holdings (2016-2021) Table 138. Aspen Holdings Recent Developments Table 139. Astellas Pharma Basic Information List Table 140. Astellas Pharma Description and Business Overview Table 141. Astellas Pharma Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 142. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Astellas Pharma (2016-2021) Table 143. Astellas Pharma Recent Developments Table 144. Endo International Basic Information List Table 145. Endo International Description and Business Overview Table 146. Endo International Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 147. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Endo International (2016-2021) Table 148. Endo International Recent Developments Table 149. Sun Pharmaceutical Basic Information List Table 150. Sun Pharmaceutical Description and Business Overview Table 151. Sun Pharmaceutical Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 152. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Sun Pharmaceutical (2016-2021) Table 153. Sun Pharmaceutical Recent Developments Table 154. Perrigo Basic Information List Table 155. Perrigo Description and Business Overview Table 156. Perrigo Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 157. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Perrigo (2016-2021) Table 158. Perrigo Recent Developments Table 159. Aerosol Basic Information List Table 160. Aerosol Description and Business Overview Table 161. Aerosol Glucocorticoid for Systemic Lupus Erythematosus Products, Services and Solutions Table 162. Revenue (US$ Million) in Glucocorticoid for Systemic Lupus Erythematosus Business of Aerosol (2016-2021) Table 163. Aerosol Recent Developments Table 164. North America Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2021) & (US$ Million) Table 165. North America Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2022-2027) & (US$ Million) Table 166. Europe Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2021) & (US$ Million) Table 167. Europe Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2022-2027) & (US$ Million) Table 168. Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Size by Region (2016-2021) & (US$ Million) Table 169. Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Size by Region (2022-2027) & (US$ Million) Table 170. Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Share by Region (2016-2021) Table 171. Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Share by Region (2022-2027) Table 172. Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2016-2021) & (US$ Million) Table 173. Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2022-2027) & (US$ Million) Table 174. Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Size by Players (2016-2021) & (US$ Million) Table 175. Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Size by Country (2022-2027) & (US$ Million) Table 176. Glucocorticoid for Systemic Lupus Erythematosus Market Trends Table 177. Glucocorticoid for Systemic Lupus Erythematosus Market Drivers Table 178. Glucocorticoid for Systemic Lupus Erythematosus Market Challenges Table 179. Glucocorticoid for Systemic Lupus Erythematosus Market Restraints Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Glucocorticoid for Systemic Lupus Erythematosus Market Share by Regions: 2021 VS 2027 Figure 4. Global Glucocorticoid for Systemic Lupus Erythematosus Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Share by Type in 2021 & 2027 Figure 11. Hydrocortisone Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Prednison Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Prednisolone Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Triamcinolone Acetonide Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Dexamethasone Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Betamethasone Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Share by Application in 2021 & 2027 Figure 18. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Pharmacy Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. Glucocorticoid for Systemic Lupus Erythematosus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Top 5 and Top 10 Players Glucocorticoid for Systemic Lupus Erythematosus Market Share in 2020 Figure 24. North America Glucocorticoid for Systemic Lupus Erythematosus Market Share by Country (2016-2027) Figure 25. United States Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 26. Canada Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 27. Germany Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 28. France Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 29. U.K. Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 30. Italy Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 31. Russia Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 32. Nordic Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 33. Rest of Europe Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Share by Region (2016-2027) Figure 35. China Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 36. Japan Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 37. South Korea Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 38. Southeast Asia Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 39. India Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 40. Australia Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 42. Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Share by Country (2016-2027) Figure 43. Mexico Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 44. Brazil Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Latin America Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 46. Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Share by Country (2016-2027) Figure 47. Turkey Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 48. Saudi Arabia Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 49. UAE Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 50. Rest of Middle East & Africa Glucocorticoid for Systemic Lupus Erythematosus Market Size (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation

Pfizer Sanofi Teva Akorn GSK Bausch and Lomb Bayer Pharmas Fougera Pharms Hikma Intl Pharms Impax Labs Lannett Merck Novartis Sandoz TARO Valeant Wockhardt Solvay Pharma Alcon Paladin Labs Adcock Ingram ADARE Pharmaceuticals Aspen Holdings Astellas Pharma Endo International Sun Pharmaceutical Perrigo Aerosol